Michal Abrahamowicz, PhD
biostatistics
cohort studies
comparative effectiveness
confounding
instrumental variables
Banner - Cardiovascular Health across the Lifespan Program -CHAL
CHAL | Cardiovascular Health across the Lifespan Program
CHAL Researchers
Our Researchers
The Cardiovascular Health Across the Lifespan (CHAL) Program brings together seven basic researchers, thirty clinician-scientists and eight health outcomes researchers. Researchers from the Centre for Translational Biology (CTB) conduct basic research projects related to vascular function and related diseases, especially atherosclerosis, hypercholesterolemia and vascular injury. Investigators from the Centre for Innovative Medicine (CIM) focus their research on surgery outcomes and on improving prevention and care in patients affected by such cardiac diseases as heart failure, arrhythmias and valve diseases. Investigators from the Centre for Outcomes Research and Evaluation (CORE) seek to develop networks, databases and new tools to improve population health. These include epidemiological outcome and intervention studies on congenital heart disease (CHD), and different factors (genetic, environmental, gender-based) for cardiovascular diseases. CHAL researchers are based at the Glen site, at the heritage site of the Royal Victoria Hospital of the MUHC and at 5252 de Maisonneuve Boulevard W.
Researchers List Filter - CHAL
Asset Publisher
Displaying 50 result(s).
 | CORE |
 | Amal Bessissow, MD, M.Sc., FRCPCperioperative medicine cardiovascular outcomes six-minute walk test CIM |
 | James Brophy, MD, PhDrisk assessment Bayesian analysis pharmacoepidemiology CORE |
| | Renzo Cecere, MDHeart failure heart assist devices mitral valve stem cells medical device design CTB |
 | Dominic Chalut, MDasthma toxicology quality assurance trauma pediatric emergency medicine CIM |
 | Robert Côté, MDstroke stroke prevention acute management clinical research CIM |
| | Stella Daskalopoulou, MD, M.Sc., DIC, PhDatherosclerosis vascular biology arterial stiffness and vessel hemodynamics hypertension cardiovascular risk factors CTB |
 | Natalie Dayan, MD, M.Sc., FRCPCepidemiology vascular perinatal women's health CORE |
 | James Engert, PhDgenetic association studies single-nucleotide polymorphisms (SNPs) gene-environment interactions atherosclerosis aortic stenosis CTB |
| | Vidal Essebag, MD, PhDEpidemiology statistical analysis methodology database analysis data management CIM |
 | Matthias Friedrich, MD, FESC, FACCCardiovascular magnetic resonance myocardial ischemia coronary heart disease acute myocardial infarction myocarditis CIM |
 | Jacques Genest, MD, FRCP(C)lipoproteins high-density lipoprotein (HDL) familial hypercholesterolemia genetics ABCA1 CTB |
 | Nadia Giannetti, MDDéfaillance cardiaque greffe cardiaque cardiomyopathie heart transplantation CIM |
| | Mark Goldberg, BSc, MSc, PhDepidemiology environment occupation cancer cardiorespiratory diseases CORE |
| | Ronald Gottesman, MDSimulation medical education clinical trials expert systems |
 | Thao Huynh, MD, PhDcardiovascular sex and gender ethnicity knowledge translation guidelines CIM |
| | CIM |
| | Robert Kiss, PhDcholesterol intracellular trafficking cell biology microscopy CTB |
 | Kevin Lachapelle, MDMarrow stromal cells angiogenesis revascularization CIM |
 | Ilka Lowensteyn, PhDCardiac rehabilitation exercise physiology kinesiology prevention wellness CIM |
| | Sheldon Magder, MDVascular biology endothelial function nitric oxide estrogen oxygen radicals CIM |
 | Ariane Marelli, MD, MPH, FRCPC, FACC, FAHAhealth services epidemiology congenital heart disease cardiovascular cardiology CORE |
 | David Mulder, MDGeneral thoracic surgery lung cancer thoracic trauma airway injury sports medicine CIM |
| | Nicolo Piazza, MD, PhD, FRCO(C), FESCAortic Valve mitral Valve transcatheter valves transcatheter aortic valve implantation transcatheter aortic valve replacement CIM |
 | Louise Pilote, MD, MPH, PhDpharmacoepidemiology comparative effectivenesse sex differences in cardiovascular diseases outcomes research cardiovascular epidemiology CORE |
 | Marc Rodger, MD, M.Sc.Venous thrombosis pulmonary embolism pregnancy anticoagulation diagnosis CORE |
| | Adel Schwertani, PhDCardiology heart vasoactive substances atherosclerosis pulmonary hypertension CTB |
 | Sam Shemie, MDBrain death neurological determination of death organ donation organ donor management pediatric CIM |
| | Dominique Shum-Tim, MD, M.Sc.Pediatric cardiac surgery cardiopulmonary bypass hypothermia circulatory arrest systemic inflammatory response CIM |
| | Allan Sniderman, MDPrevention cardiovascular disease atherosclerosis apoB CORE |
| | Susan Solymoss, MDthrombosis anticoagulation treatment prevention hemostasis CIM |
| | Oren Steinmetz, MDaneurysm carotid stenosis endovascular CIM |
 | Robyn Tamblyn, MScN, M.Sc., PhD, CMhealth services medical education medical informatics practice changes pharmacoepidemiology CORE |
 | George Thanassoulis, MDGenetics genomics cardiovascular disease aortic stenosis myocardial infarction CORE |